Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Actinium Pharmaceuticals Inc
ATNM
Healthcare
Biotechnology
Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company advances two clinical stage product candidates, Actimab-A, to treat patients with myeloid malignancies including acute myeloid leukemia and myelodysplastic syndromes; and Iomab-ACT, to improve...
patient access to and outcomes with cellular therapies, such as CAR-T for various blood cancer indications and gene therapies for non-malignant hematologic disorders such as sickle cell disease. It also develops ATNM-400, a preclinical non-prostate specific-membrane antigen targeting radiotherapy utilizing the Actinium-225 radioisotope for patients with prostate cancer. In addition, the company's Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). Further, it engages with the National Cancer Inst...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NYSEAM:ATNM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
EllaMae
X
Post by
EllaMae
on Feb 19, 2022 1:40am
FSD Pharma; Recapping 2021 and What to Look Forward in 2022
(0)
•••
EllaMae
X
Post by
EllaMae
on Feb 04, 2022 10:41am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid
...more
(0)
•••
EllaMae
X
Post by
EllaMae
on Jan 01, 2022 12:41am
FSD Pharma Announces Share Repurchase Program
FSD Pharma Announces Share Repurchase Program TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding
...more
(0)
•••
EllaMae
X
Post by
EllaMae
on Dec 10, 2021 2:14am
FSD Pharma Establishes New Regulatory Advisory Board
FSD Pharma Establishes New Regulatory Advisory Board with the Appointment of Joga Gobburu, Ph.D., and Mary Melnyk, Ph.D., as Members Regulatory Advisory Board will oversee the drug development
...more
(0)
•••
EllaMae
X
Post by
EllaMae
on Dec 06, 2021 10:17pm
H.C. Wainwright 2nd Annual Psychedelics Virtual Conference
FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD
...more
(0)
•••
EllaMae
X
Post by
EllaMae
on Dec 03, 2021 11:35pm
FSD Pharma at the H.C. Wainwright 2nd Annual Psychedelics
FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD
...more
(0)
•••
EllaMae
X
Post by
EllaMae
on Dec 03, 2021 2:47am
FSD Pharma: Demonstrating the Positive Effects of Lucid-MS
FSD Pharma Unveils Videos Demonstrating Positive Effects of
...more
(0)
•••
EllaMae
X
Post by
EllaMae
on Dec 01, 2021 8:22pm
📰📣iMining Technologies Launches Concierge Service📢📣📣
↓↓↓↓↓↓↓↓↓↓↓↓↓Click the link for the Full Details of the Article: ↓↓↓↓↓↓↓↓↓↓↓↓↓ BitBit Financial Inc., a wholly owned subsidiary of iMining Technologies Inc., has set-up concierge
...more
(0)
•••
EllaMae
X
Post by
EllaMae
on Nov 26, 2021 11:28pm
🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣
(0)
•••
EllaMae
X
Post by
EllaMae
on Nov 23, 2021 8:35pm
📰📣Anthony Durkacz on Building a Turnaround at FSD Pharma🎥
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Pinnacle Provides Progress Update for El Potrero Gold-Silver Project
Allied Critical Metals Announces Receipt of Environmental Permit for the Borralha Tungsten Project in Portugal
Team Spotlight: Every discovery begins with the people behind it
Sranan Gold Reports 11 M Grading 7.33 g/t Gold Including 4 M at 14.59 g/t Gold
Global Currency Shifts Are Reshaping Commodities. Learn How. Secure Your Seat at VRIC 2026
Podcasts